Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-277503
Filing Date
2025-11-12
Accepted
2025-11-12 16:03:09
Documents
20

Document Format Files

Seq Description Document Type Size
1 424B5 d159388d424b5.htm 424B5 852196
2 EX-FILING FEES d159388dexfilingfees.htm   iXBRL EX-FILING FEES 21050
3 GRAPHIC g159388g01n01.jpg GRAPHIC 70517
4 GRAPHIC g159388g01n44.jpg GRAPHIC 25650
5 GRAPHIC g159388g02n44.jpg GRAPHIC 29550
6 GRAPHIC g159388g40n40.jpg GRAPHIC 26326
7 GRAPHIC g159388g41n41.jpg GRAPHIC 27467
8 GRAPHIC g159388g42n42.jpg GRAPHIC 26842
9 GRAPHIC g159388g43n43.jpg GRAPHIC 26990
10 GRAPHIC g159388g99p03.jpg GRAPHIC 51694
  Complete submission text file 0001193125-25-277503.txt   1362209

Data Files

Seq Description Document Type Size
23 EXTRACTED XBRL INSTANCE DOCUMENT d159388dexfilingfees_htm.xml XML 6441
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-291384 | Film No.: 251472504
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)